Gainsville, FL, United States of America

Jonathan Charnecki


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jonathan Charnecki

Introduction

Jonathan Charnecki is an accomplished inventor based in Gainesville, FL (US). He has made significant contributions to the field of biochemistry, particularly in the development of antibodies. His innovative work has led to the creation of a patent that addresses important challenges in the production of specific antibodies.

Latest Patents

Jonathan Charnecki holds a patent for the "Production of anti-peptide antibodies against cytochrome P450." This patent discloses a method for producing form-specific and/or inhibitory antibodies against cytochrome P450 proteins. The method involves selecting a specific cytochrome P450 protein, determining its amino acid sequence, and aligning it with a comparison sequence using an alignment algorithm. A peptide sequence corresponding to a substrate recognition site is identified, and the peptide is prepared as an immunogen to produce the desired antibodies.

Career Highlights

Charnecki's career is marked by his dedication to advancing biotechnological methods. His work at Oxford Biomedical Research, Inc. has positioned him as a key figure in the research community. His innovative approaches have not only contributed to scientific knowledge but have also paved the way for practical applications in medicine and pharmacology.

Collaborations

Throughout his career, Jonathan has collaborated with notable colleagues, including Hyesook Kim and David A Putt. These partnerships have enhanced his research efforts and have led to further advancements in the field.

Conclusion

Jonathan Charnecki's contributions to the field of biochemistry through his innovative patent work exemplify the impact of dedicated inventors in advancing scientific research. His methods for producing specific antibodies represent a significant step forward in biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…